Metagenomi, Inc.
Discovering novel gene editing tools from nature for curative genetic medicines.
MGX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US59102M1045
- LEI:
- Country:
- United States of America
- Address:
- 5959 HORTON STREET, 94608 EMERYVILLE
- Website:
- https://metagenomi.co/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Metagenomi, Inc. is a genetic medicines company that develops potentially curative therapeutics using a proprietary, metagenomics-powered genome editing toolbox. The company leverages artificial intelligence and high-throughput screening to mine natural ecosystems for novel cellular systems, discovering and developing a diverse suite of next-generation gene editing tools. Its comprehensive toolbox includes programmable nucleases, base editors, and RNA- and DNA-mediated integration systems (such as prime editing and CRISPR-associated transposases). Metagenomi's strategy focuses on advancing its wholly-owned pipeline of in vivo gene editing therapies for devastating diseases while also pursuing technology out-licensing for ex vivo cell therapy applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Metagenomi, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Metagenomi, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Metagenomi, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
